108 related articles for article (PubMed ID: 24528082)
1. Prognostic factors in adult patients with solid cancers and bone marrow metastases.
Hung YS; Chou WC; Chen TD; Chen TC; Wang PN; Chang H; Hsu HC; Shen WC; Cheng WH; Chen JS
Asian Pac J Cancer Prev; 2014; 15(1):61-7. PubMed ID: 24528082
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of gastric cancer patients with bone marrow metastases.
Kim HS; Yi SY; Jun HJ; Lee J; Park JO; Park YS; Jang J; Kim HJ; Ko Y; Lim HY; Kang WK
Oncology; 2007; 73(3-4):192-7. PubMed ID: 18418012
[TBL] [Abstract][Full Text] [Related]
3. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of 30 patients with bone marrow metastases.
Zhou MH; Wang ZH; Zhou HW; Liu M; Gu YJ; Sun JZ
J Cancer Res Ther; 2018 Jun; 14(Supplement):S512-S515. PubMed ID: 29970716
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Prognostic Score to Predict Survival in Adult Patients With Solid Tumors and Bone Marrow Metastases.
Chou WC; Yeh KY; Peng MT; Chen JS; Wang HM; Lin YC; Liu CT; Li SH; Chang PH; Wang CH; Chen PT; Hung YS; Lu CH
Medicine (Baltimore); 2015 Jun; 94(23):e966. PubMed ID: 26061333
[TBL] [Abstract][Full Text] [Related]
6. Does the immunocytochemical detection of epithelial cells in bone marrow (micrometastasis) influence the time to biochemical relapse after radical prostatectomy?
Weckermann D; Wawroschek F; Krawczak G; Haude KH; Harzmann R
Urol Res; 1999 Aug; 27(4):285-90. PubMed ID: 10460901
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics and Prognosis of Gastrointestinal Metastases in Solid Tumor Patients: A Retrospective Study and Review of Literatures.
Lin L; Wang X; Tang C; Liang J
Anal Cell Pathol (Amst); 2019; 2019():4508756. PubMed ID: 31929965
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Factors and Comparison of Conservative Treatment, Percutaneous Vertebroplasty, and Open Surgery in the Treatment of Spinal Metastases from Lung Cancer.
Yang SZ; Tang Y; Zhang Y; Chen WG; Sun J; Chu TW
World Neurosurg; 2017 Dec; 108():163-175. PubMed ID: 28867314
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.
Gravis G; Boher JM; Fizazi K; Joly F; Priou F; Marino P; Latorzeff I; Delva R; Krakowski I; Laguerre B; Walz J; Rolland F; Théodore C; Deplanque G; Ferrero JM; Pouessel D; Mourey L; Beuzeboc P; Zanetta S; Habibian M; Berdah JF; Dauba J; Baciuchka M; Platini C; Linassier C; Labourey JL; Machiels JP; El Kouri C; Ravaud A; Suc E; Eymard JC; Hasbini A; Bousquet G; Soulie M; Oudard S
Eur Urol; 2015 Aug; 68(2):196-204. PubMed ID: 25277272
[TBL] [Abstract][Full Text] [Related]
10. A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis.
Park HS; Rha SY; Kim HS; Hyung WJ; Park JS; Chung HC; Noh SH; Jeung HC
Oncology; 2011; 80(1-2):142-50. PubMed ID: 21677462
[TBL] [Abstract][Full Text] [Related]
11. Recent aspects for disseminated carcinomatosis of the bone marrow associated with gastric cancer: What has been done for the past, and what will be needed in future?
Iguchi H
World J Gastroenterol; 2015 Nov; 21(43):12249-60. PubMed ID: 26604634
[TBL] [Abstract][Full Text] [Related]
12. Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus.
Janni W; Hepp F; Strobl B; Rack B; Rjosk D; Kentenich C; Schindlbeck C; Hantschmann P; Pantel K; Sommer H; Braun S
Cancer; 2003 Jan; 97(2):405-11. PubMed ID: 12518364
[TBL] [Abstract][Full Text] [Related]
13. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
[TBL] [Abstract][Full Text] [Related]
14. The assessment of clinicopathological features, therapy pattern and survival benefit of 162 gastric cancers with liver metastases.
Li J; Lu M; Li J; Zhang X; Li Y; Zhan X; Shen L
Hepatogastroenterology; 2013 May; 60(123):628-32. PubMed ID: 23108083
[TBL] [Abstract][Full Text] [Related]
15. [Clinical Analysis of Small Cell Lung Cancer with Bone Marrow Metastases].
Che Y; Luo Y; Wang D; Shen D; Yang L
Zhongguo Fei Ai Za Zhi; 2018 May; 21(5):403-407. PubMed ID: 29764591
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and treatment of patients with lung adenocarcinoma with bone marrow metastasis.
Wang D; Luo Y; Shen D; Yang L; Liu HY; Che YQ
Tumori; 2019 Oct; 105(5):388-393. PubMed ID: 30931812
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of bone marrow biopsy for bone marrow metastatic tumor with unknown primary tumor site].
Wu Y; Yao LQ; Cheng J; Tian H
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1069-71. PubMed ID: 20501396
[TBL] [Abstract][Full Text] [Related]
18. Predictors of survival in patients with bone metastasis of lung cancer.
Sugiura H; Yamada K; Sugiura T; Hida T; Mitsudomi T
Clin Orthop Relat Res; 2008 Mar; 466(3):729-36. PubMed ID: 18196360
[TBL] [Abstract][Full Text] [Related]
19. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE
J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381
[TBL] [Abstract][Full Text] [Related]
20. [Pathologic diagnosis of nonhematological tumor metastasis in bone marrow by marrow aspiration and trephine biopsy].
Tao Y; Li X; Wu LY; Liu YZ; Song LX; Chang CK; Pu Q
Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):112-3. PubMed ID: 20388377
[No Abstract] [Full Text] [Related]
[Next] [New Search]
